{"id":916,"date":"2013-03-01T10:37:57","date_gmt":"2013-03-01T10:37:57","guid":{"rendered":"http:\/\/www.sumpraxis.com\/?p=916"},"modified":"2013-03-05T10:54:05","modified_gmt":"2013-03-05T10:54:05","slug":"august-25-2008","status":"publish","type":"post","link":"http:\/\/www.sumpraxis.com\/index.php\/august-25-2008","title":{"rendered":"August 25, 2008"},"content":{"rendered":"<p><strong>Sumpraxis helps Cybergene find distribution channels in the emerging Indian Markets\u2026\u2026<\/strong><\/p>\n<p>Industry : <strong>Healthcare<\/strong><\/p>\n<p>Product : <strong>IVD Kit<\/strong><\/p>\n<p>Within months of initiating rigorous market research, partner identification program Sumpraxis finds Cyebrgene its first Indian market Channel partner, Ranbaxy. Sumpraxis served Cybergene with market potential research for their product in India, identification of potential channel partners, pilot tests and trials, first order placement and technical support coordination.<br \/>\n<!--more--><br \/>\nRanbaxy a leading International pharmaceutical company, will be introducing Cybergene IVD kits in the Indian market in September\/October 2008.<\/p>\n<p>Sumpraxis assists Small and Medium sized International companies like Cybergene with India Market entry advisory services, identifying Channel partners, assist in commercial negotiations, advising on regulatory implications.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sumpraxis helps Cybergene find distribution channels in the emerging Indian Markets\u2026\u2026 Industry : Healthcare Product : IVD Kit Within months of initiating rigorous market research, partner identification program Sumpraxis finds Cyebrgene its first Indian market Channel partner, Ranbaxy. Sumpraxis served Cybergene with market potential research for their product in India, identification of potential channel partners, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[28],"tags":[],"class_list":["post-916","post","type-post","status-publish","format-standard","hentry","category-28"],"_links":{"self":[{"href":"http:\/\/www.sumpraxis.com\/index.php\/wp-json\/wp\/v2\/posts\/916"}],"collection":[{"href":"http:\/\/www.sumpraxis.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.sumpraxis.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.sumpraxis.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.sumpraxis.com\/index.php\/wp-json\/wp\/v2\/comments?post=916"}],"version-history":[{"count":3,"href":"http:\/\/www.sumpraxis.com\/index.php\/wp-json\/wp\/v2\/posts\/916\/revisions"}],"predecessor-version":[{"id":1132,"href":"http:\/\/www.sumpraxis.com\/index.php\/wp-json\/wp\/v2\/posts\/916\/revisions\/1132"}],"wp:attachment":[{"href":"http:\/\/www.sumpraxis.com\/index.php\/wp-json\/wp\/v2\/media?parent=916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.sumpraxis.com\/index.php\/wp-json\/wp\/v2\/categories?post=916"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.sumpraxis.com\/index.php\/wp-json\/wp\/v2\/tags?post=916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}